The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay (Q44206965)

30 November 2017

The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay (English)

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

27 October 2022

4

F. Delpeyroux

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679577

27 October 2022

author name string

J. Balanant

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679577

27 October 2022

S. Guillot

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679577

27 October 2022

A. Candrea

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679577

27 October 2022

R. Crainic

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679577

27 October 2022

language of work or name

English

0 references

publication date

1 October 1991

1 reference

full work available at URL

30 November 2017

10

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:004268229190434D?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

https://api.elsevier.com/content/article/PII:004268229190434D?httpAccept=text/plain

27 October 2022

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

27 October 2022

1 reference

30 November 2017

184

1 reference

30 November 2017

645-654

1 reference

30 November 2017

2

1 reference

Detection by monoclonal antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 and on heat-inactivated virions

30 November 2017

1

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies

27 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Molecular pathogenesis of type 2 poliovirus in mice

27 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Determination of type 1 poliovirus subtype classes with neutralizing monoclonal antibodies

27 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Monoclonal antibodies specific for the Sabin vaccine strain of poliovirus 3

27 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Three-dimensional structure of poliovirus at 2.9 A resolution.

27 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

The nucleotide sequence of a type 3 poliovirus isolated during a recent outbreak of poliomyelitis in Finland.

27 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Monoclonal antibodies of four different specificities for neutralization of type 1 polioviruses

27 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Individual-specific ‘fingerprints’ of human DNA

27 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Multiple Genetic Changes Can Occur in the Oral Poliovaccines upon Replication in Humans

27 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Molecular Epidemiology of Polioviruses

27 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Primary structure, gene organization and polypeptide expression of poliovirus RNA.

27 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing

27 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Antigenic and molecular properties of type 3 poliovirus responsible for an outbreak of poliomyelitis in a vaccinated population

27 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Antigenic analysis of polioviruses by kinetic studies of serum neutralization

27 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Comparative biochemical studies of type 3 poliovirus

27 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

The use of a modified Wecker technique for the serodifferentiation of type 1 polioviruses related and unrelated to Sabin's vaccine strain. I. Standardization and evaluation of the test

27 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans

27 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Monoclonal antibodies to polioviruses. Production of specific monoclonal antibodies to the Sabin vaccine strains

27 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome

27 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Geographic distribution of wild poliovirus type 1 genotypes.

27 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

History of Sabin attenuated poliovirus oral live vaccine strains

27 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world

27 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia

27 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Control of Influenza and Poliomyelitis with Killed Virus Vaccines

27 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Poliomyelitis outbreak in Israel in 1988: a report with two commentaries

27 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1

27 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b

27 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants.

27 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Intratypic Serodifferentiation of Poliomyelitis Virus Strains by Strain-Specific Antisera

27 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

Markers of poliovirus strains isolated from cases temporally associated with the use of live poliovirus vaccine: report on a W.H.O. collaborative study

27 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90434-D

27 October 2022

Identifiers

1 reference

30 November 2017

1 reference